The Augusta University Georgia Cancer Center brings together a team of basic science researchers, clinicians, radiation oncologists, nurse navigators and patient support staff to create a community fostering innovation and care focused on improving the lives of our patients. This team approach is focused on patients across the state of Georgia and neighboring states providing access to more first-in-the-nation clinical trials, world-renowned experts and a multidisciplinary approach that keeps the patient at the center of care. Research at the Augusta University Georgia Cancer Center’s M. Bert Storey Research Building focuses on the most promising pathways for the prevention and treatment of cancer. Several of our researchers are involved with investigator-initiated clinical trials, transitioning their research into the clinic.
October 22, 2024
Article
Jorge Cortes, MD, discusses findings with bosutinib in CML and the importance of dose adjustment as a strategy for managing bosutinib-related AEs.
October 21, 2024
Article
Jorge Cortes, MD, inaugural editor-in-chief of Blood Global Hematology, details what type of research the new journal will highlight and its importance.
October 23, 2023
Article
Building an innovative cancer research project takes time, creativity, and most importantly, a team of scientists working together on why a new way to treat cancer or keep the cancer from spreading to other parts of the body.
September 11, 2023
Video
Marisol Miranda-Galvis, DDS, MS, PhD, discusses the investigation of disparities in survival outcomes of patients with hematologic malignancies relating to social determinants.
September 07, 2023
Article
Findings from a systematic review of several observational studies reveal that increasing disparities in survival outcomes within hematologic malignancies can be primarily attributed to 5 social determinants of health: lack of access to health insurance, treatment at a non-academic facility, low income or education level, and unmarried status.
May 29, 2023
Article
The Georgia Cancer Center Pharmacogenomics Program has launched its pharmacogenomics testing services for Georgia Cancer Center patients and oncologists.
May 19, 2023
Article
Acute myeloid leukemia is a cancer that affects blood cells in the bone marrow- the spongy tissue inside certain bones where new blood cells are made.
February 22, 2023
Article
Anand P. Jillella, MD, has been selected as one of 20 Georgia “Trailblazers” in cancer care by the Georgia Center for Oncology Research and Education.
February 09, 2023
Article
Multiple teams working inside the Georgia Cancer Center at the Medical College of Georgia at Augusta University are committed to closing care gaps across Georgia.
February 07, 2023
Article
Cardiovascular diseases are the follow-up threats many men face after undergoing androgen deprivation therapy, also known as hormonal treatment, for prostate cancer.
December 21, 2021
Article
Jorge E. Cortes, MD, has been an investigative leader for nearly 30 years in the development of numerous leukemia treatments.
October 08, 2021
Article
The Paceline Ride, LLC team delivered a check for $126,000 to the Georgia Cancer Center at Augusta University.
October 01, 2021
Article
The Augusta University community is encouraged to participate in this year’s Paceline bicycle ride on October 16.
April 24, 2020
Video
Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the challenges of using ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms (MPNs).
April 14, 2020
Article
Jorge E. Cortes, MD, discusses managing treatment toxicities to optimize therapeutic outcomes in patients with CML and MPNs.
March 19, 2020
Article
Jorge E. Cortes, MD, discusses the evolution of multiple myeloma treatment, the role of BCMA-directed therapies, and remaining questions that need to be addressed in this space
March 19, 2020
Video
Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the advantage of BCMA-targeted therapy in multiple myeloma.
January 13, 2018
Video
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.
November 09, 2017
Video
Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the GOG/NRG-0265 study in cervical cancer.
July 12, 2017
Article
The future of treatment for ovarian cancer may lie in immunotherapy combinations with PARP inhibitors or checkpoint inhibitors.